STK11 and non-small cell lung carcinoma: Further, LKB1 inactivation induces a redox imbalance to promote transdifferentiation from lung adenocarcinoma to lung squamous cell carcinoma in NSCLC, which leads resistance to anti-tumor therapy [90].